摘要
经皮冠状动脉介入治疗(PCI)已成为冠心病血管重建的主要治疗手段,但术后无复流等问题也日渐突出。近年来,从伏邪理论探讨相关问题的研究思路逐渐清晰,应用中医药防治PCI术后危险因素取得了一定的研究进展。结合无复流诊疗现状,从伏邪和治未病角度出发,提出预防伏邪产生及祛除伏邪是防治PCI术后无复流、慢血流等危险因素的重要手段,为中西医结合治疗拓宽了思路。
Percutaneous coronary intervention（PCI） has become the main treatment in revascularization of coronary heart disease today, but at the same time,it can increase the risk of PCI no - reflow. Recently, the research on ideas of Fuxie theory and issues related to no - reflow has gradually clear, the application of Chinese medicine in preventing and treating the risk factors of PCI has made some progress. This article discoursed from the point of view of Fuxie theory and preventive treatment of disease, providing reference to combat PCI postopertive no - reflow treatment using the combination of Chinese and Western medicine methods.
出处
《中华中医药学刊》
CAS
2012年第11期2430-2431,共2页
Chinese Archives of Traditional Chinese Medicine
基金
国家自然科学基金资助项目(30901890)
关键词
伏邪
治未病
PCI术后无复流
中医药
Fuxie theory
preventive treatment of disease
PCI postopertive no. reflow
TCM
